Dominion Energy Inc vs Viatris Inc — how do they compare? Dominion Energy Inc trades at $61.71 (market cap $54.31B), while Viatris Inc trades at $17.58 (market cap $20.03B). The key difference: Dominion Energy Inc is far larger — about 2.7× Viatris Inc's market cap, and Dominion Energy Inc pays the higher dividend (4.32%). Which is the better fit depends on your goals — on Pluang, investors hold Dominion Energy Inc for 76 Days and Viatris Inc for 57 Days on average.
| D | VTRS | |
|---|---|---|
Market Cap | $54.31B | $20.03B |
Volume | 6,944,775 | 14,109,977 |
Sector | Utilities | Health |
52-Week High | $71.67 | $18.27 |
52-Week Low | $57.08 | $9.74 |
Typical Hold Time | 76 Days | 57 Days |
Enterprise Value | $108.43B | $32.15B |
Dividend Yield | 4.32% | 2.75% |
Signals from Pluang's Aura AI — not financial advice
Dominion Energy (D) trades at $61.53, down 0.76% on the day, with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with revenue growth from $14.5B in 2024 to $16.5B in 2025 and net income margin improving to 18.16%. Analyst consensus is mixed with 36% buy ratings but a $71.56 price target suggesting 16% upside. The pending merger with NextEra Energy dominates recent news coverage, creating both opportunity and regulatory uncertainty.
The stock presents a value opportunity with reasonable valuation multiples (P/E 21.37, P/S 2.96) and consistent profitability, though technical indicators suggest near-term pressure. Key risks include merger approval uncertainty, high debt levels, and interest rate sensitivity. The dividend yield of approximately 4.4% provides income support while investors await merger resolution and continued execution on data center and renewable energy investments.
Viatris (VTRS) trades at $17.625, up 0.77% with a bullish technical signal. The company shows mixed fundamentals with declining revenue from $16.3B in 2022 to $14.3B in 2025 and negative net income margins, though recent quarters have beaten EPS estimates. Positive cash flow trends and a $0.12 dividend signal financial stability. Analyst consensus is mixed with 38% buy ratings and a $22.17 price target suggesting 26% upside.
The outlook balances operational strength against profitability challenges. Investment appeal lies in value metrics (P/S 1.38), consistent earnings beats, and dividend yield, but risks include sustained negative margins, high debt, and competitive pressures. The stock's re-rating depends on margin improvement and pipeline execution.
Trailing returns across standard periods
Latest headlines on both assets
Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion owns a liquefied natural gas export facility in Maryland and is constructing a 5.2 GW wind farm off the Virginia Beach coast.
Read more on D →Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →